7/29/24 16:18 | 7/25/24 | RGLS | Health | Drug | Pharmaceutical Preparations | Collier Kathryn J | CA | D | | P | 7 | 1.82 | 0 | 4 | 146 | 7 | D | | | | | | | | | | | | | | |
1/18/24 20:24 | 1/18/24 | RGLS | Health | Drug | Pharmaceutical Preparations | Calsada Crispina | CA | O | CFO | S | -7 | 1.19 | 0 | -5 | -49 | 6 | D | | | | | | | | | | | | | | |
1/18/24 20:23 | 1/18/24 | RGLS | Health | Drug | Pharmaceutical Preparations | Aker Christopher Ray | CA | O | SVP,GC | S | -7 | 1.19 | 0 | -5 | -35 | 10 | D | | | | | | | | | | | | | | |
1/18/24 20:22 | 1/18/24 | RGLS | Health | Drug | Pharmaceutical Preparations | Hagan Joseph P | CA | DO | CEO | S | -17 | 1.19 | 0 | -15 | -20 | 57 | D | | | | | | | | | | | | | | |
2/7/22 17:09 | 2/4/22 | RGLS | Health | Drug | Pharmaceutical Preparations | Drygin Denis | CA | O | Chief Sc | P | 5 | 0.2300 | 0 | 23 | New | 23 | D | | | | | | | | | | | | | | |
1/26/22 16:13 | 1/26/22 | RGLS | Health | Drug | Pharmaceutical Preparations | Hagan Joseph P | CA | DO | P,CEO | P.d | 22 | 0.2152 | 0 | 100 | 32 | 417 | D | | | | | | | | | | | | | | |
5/17/21 19:13 | 5/17/21 | RGLS | Health | Drug | Pharmaceutical Preparations | Hagan Joseph P | CA | DO | P,CEO | S | -4 | 0.8900 | 0 | -4 | -1 | 316 | D | | | | | | | | | | | | | | |
5/17/21 19:12 | 5/17/21 | RGLS | Health | Drug | Pharmaceutical Preparations | Aker Christopher Ray | CA | O | SVP,GC | S | -1 | 0.8900 | 0 | -1 | -2 | 42 | D | | | | | | | | | | | | | | |
4/16/21 16:11 | 2/16/21 | RGLS | Health | Drug | Pharmaceutical Preparations | Hagan Joseph P | CA | DO | P,CEO | S.a | -7 | 1.72 | 0 | -4 | -2 | 245 | D | | | | | | | | | | | | | | |
2/17/21 17:23 | 2/16/21 | RGLS | Health | Drug | Pharmaceutical Preparations | Aker Christopher Ray | CA | O | SVP,GC | S | -1 | 1.72 | 0 | -1 | -2 | 43 | D | | | | | | | | | | | | | | |
2/17/21 17:23 | 2/16/21 | RGLS | Health | Drug | Pharmaceutical Preparations | Hagan Joseph P | CA | DO | P,CEO | S | -7 | 1.72 | 0 | -4 | -1 | 486 | D | | | | | | | | | | | | | | |
12/7/20 17:14 | 12/4/20 | RGLS | Health | Drug | Pharmaceutical Preparations | Walker Paul Edward | MD | T | | P.d | 2,736 | 0.6220 | 0 | 4,399 | 214 | 6,451 | I | | | | | | | | | | | | | | |
12/7/20 17:13 | 12/4/20 | RGLS | Health | Drug | Pharmaceutical Preparations | Sonsini Peter W. | CA | T | | P.d | 2,736 | 0.6220 | 0 | 4,399 | 214 | 6,451 | I | | | | | | | | | | | | | | |
12/7/20 17:12 | 12/4/20 | RGLS | Health | Drug | Pharmaceutical Preparations | Sandell Scott D | MD | T | | P.d | 2,736 | 0.6220 | 0 | 4,399 | 214 | 6,451 | I | | | | | | | | | | | | | | |
12/7/20 17:12 | 12/4/20 | RGLS | Health | Drug | Pharmaceutical Preparations | Makower Joshua | MD | T | | P.d | 2,736 | 0.6220 | 0 | 4,399 | 214 | 6,451 | I | | | | | | | | | | | | | | |
12/7/20 17:11 | 12/4/20 | RGLS | Health | Drug | Pharmaceutical Preparations | Makhzoumi Mohamad | CA | T | | P.d | 2,736 | 0.6220 | 0 | 4,399 | 214 | 6,451 | I | | | | | | | | | | | | | | |
12/7/20 17:10 | 12/4/20 | RGLS | Health | Drug | Pharmaceutical Preparations | Florence Anthony A. Jr. | MD | T | | P.d | 2,736 | 0.6220 | 0 | 4,399 | 214 | 6,451 | I | | | | | | | | | | | | | | |
12/7/20 17:10 | 12/4/20 | RGLS | Health | Drug | Pharmaceutical Preparations | Chang Carmen | CA | T | | P.d | 2,736 | 0.6220 | 0 | 4,399 | 214 | 6,451 | I | | | | | | | | | | | | | | |
12/7/20 17:09 | 12/4/20 | RGLS | Health | Drug | Pharmaceutical Preparations | Behbahani Ali | MD | T | | P.d | 2,736 | 0.6220 | 0 | 4,399 | 214 | 6,451 | I | | | | | | | | | | | | | | |
12/7/20 17:08 | 12/4/20 | RGLS | Health | Drug | Pharmaceutical Preparations | Baskett Forest | MD | T | | P.d | 2,736 | 0.6220 | 0 | 4,399 | 214 | 6,451 | I | | | | | | | | | | | | | | |
12/7/20 17:06 | 12/4/20 | RGLS | Health | Drug | Pharmaceutical Preparations | Growth Equity Opportunities V, LLC | MD | T | | P.d | 2,736 | 0.6220 | 0 | 4,399 | 214 | 6,451 | D | | | | | | | | | | | | | | |
11/18/20 16:10 | 11/16/20 | RGLS | Health | Drug | Pharmaceutical Preparations | Aker Christopher Ray | CA | O | SVP,GC | S | 0 | 0.5211 | 0 | -1 | -3 | 26 | D | | | | | | | | | | | | | | |
11/18/20 16:09 | 11/16/20 | RGLS | Health | Drug | Pharmaceutical Preparations | Hagan Joseph P | CA | DO | P,CEO | S | -3 | 0.5211 | 0 | -6 | -3 | 216 | D | | | | | | | | | | | | | | |
8/17/20 20:22 | 8/14/20 | RGLS | Health | Drug | Pharmaceutical Preparations | Hagan Joseph P | CA | DO | P,CEO | S | -3 | 0.6049 | 0 | -4 | -2 | 222 | D | | | | | | | | | | | | | | |
8/17/20 20:21 | 8/14/20 | RGLS | Health | Drug | Pharmaceutical Preparations | Aker Christopher Ray | CA | O | SVP,GC | S | -1 | 0.6050 | 0 | -1 | -3 | 27 | D | | | | | | | | | | | | | | |
5/18/20 16:28 | 5/15/20 | RGLS | Health | Drug | Pharmaceutical Preparations | Hagan Joseph P | CA | DO | P,CEO | S | -3 | 0.6267 | 0 | -4 | -2 | 226 | D | | | | | | | | | | | | | | |
5/18/20 16:27 | 5/15/20 | RGLS | Health | Drug | Pharmaceutical Preparations | Aker Christopher Ray | CA | O | SVP,GC | S | -1 | 0.6268 | 0 | -1 | -3 | 28 | D | | | | | | | | | | | | | | |
2/19/20 18:09 | 2/18/20 | RGLS | Health | Drug | Pharmaceutical Preparations | Hagan Joseph P | CA | DO | P,CEO | S | -4 | 0.8304 | 0 | -4 | -2 | 231 | D | | | | | | | | | | | | | | |
2/19/20 18:08 | 2/18/20 | RGLS | Health | Drug | Pharmaceutical Preparations | Aker Christopher Ray | CA | O | SVP,GC | S | -1 | 0.8305 | 0 | -1 | -3 | 28 | D | | | | | | | | | | | | | | |
1/3/20 16:07 | 1/2/20 | RGLS | Health | Drug | Pharmaceutical Preparations | Hagan Joseph P | CA | DO | P,CEO | S | -8 | 0.9667 | 0 | -8 | -3 | 235 | D | | | | | | | | | | | | | | |
1/3/20 16:06 | 1/2/20 | RGLS | Health | Drug | Pharmaceutical Preparations | Aker Christopher Ray | CA | O | SVP,GC | S | -2 | 0.9667 | 0 | -2 | -7 | 29 | D | | | | | | | | | | | | | | |
11/15/19 17:37 | 11/14/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Aker Christopher Ray | CA | O | SVP,GC | S | -1 | 0.6400 | 0 | -1 | -3 | 32 | D | | | | | | | | | | | | | | |
11/15/19 17:36 | 11/14/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Hagan Joseph P | CA | DO | P,CEO | S | -4 | 0.6400 | 0 | -6 | -2 | 243 | D | | | | | | | | | | | | | | |
10/2/19 18:50 | 10/1/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Aker Christopher Ray | CA | O | SVP,GC | S | -2 | 0.6827 | 0 | -2 | -7 | 32 | D | | | | | | | | | | | | | | |
10/2/19 18:17 | 10/1/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Hagan Joseph P | CA | DO | P,CEO | S | -6 | 0.6827 | 0 | -9 | -3 | 249 | D | | | | | | | | | | | | | | |
8/16/19 16:17 | 8/15/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Hagan Joseph P | CA | DO | P,CEO | S | -2 | 0.5506 | 0 | -4 | -2 | 258 | D | | | | | | | | | | | | | | |
8/16/19 16:16 | 8/15/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Aker Christopher Ray | CA | O | SVP,GC | S | 0 | 0.5506 | 0 | -1 | -3 | 35 | D | | | | | | | | | | | | | | |
7/2/19 17:42 | 7/1/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Hagan Joseph P | CA | DO | P,CEO | S | -8 | 1.31 | 0 | -6 | -2 | 262 | D | | | | | | | | | | | | | | |
7/2/19 17:42 | 7/1/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Aker Christopher Ray | CA | O | SVP,GC | S | -3 | 1.31 | 0 | -2 | -6 | 36 | D | | | | | | | | | | | | | | |
7/2/19 17:41 | 7/1/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO | S | -4 | 1.31 | 0 | -3 | -3 | 78 | D | | | | | | | | | | | | | | |
5/16/19 17:25 | 5/16/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Hagan Joseph P | CA | DO | P,CEO | S.d | -48 | 1.22 | 0 | -39 | -13 | 268 | D | | | | | | | | | | | | | | |
5/16/19 17:21 | 5/15/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO | S.d | -14 | 1.41 | 0 | -10 | -11 | 81 | D | | | | | | | | | | | | | | |
5/16/19 17:21 | 5/15/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Aker Christopher Ray | CA | O | SVP,GC | S.d | -10 | 1.41 | 0 | -7 | -10 | 59 | D | | | | | | | | | | | | | | |
5/10/19 10:59 | 5/7/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Walker Paul Edward | MD | T | | P.ad | 1,228 | 1.08 | 0 | 1,137 | 124 | 2,052 | I | | | | | | | | | | | | | | |
5/9/19 18:08 | 5/7/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Walker Paul Edward | MD | D | | P.d | 1,228 | 1.08 | 0 | 1,137 | 124 | 2,052 | I | | | | | | | | | | | | | | |
5/9/19 18:07 | 5/7/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Sonsini Peter W. | CA | T | | P.d | 1,228 | 1.08 | 0 | 1,137 | 124 | 2,052 | I | | | | | | | | | | | | | | |
5/9/19 18:07 | 5/7/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Sandell Scott D | MD | T | | P.d | 1,228 | 1.08 | 0 | 1,137 | 124 | 2,052 | I | | | | | | | | | | | | | | |
5/9/19 18:06 | 5/7/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Mott David M | MD | T | | P.d | 1,228 | 1.08 | 0 | 1,137 | 124 | 2,052 | I | | | | | | | | | | | | | | |
5/9/19 18:06 | 5/7/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Makower Joshua | MD | T | | P.d | 1,228 | 1.08 | 0 | 1,137 | 124 | 2,052 | I | | | | | | | | | | | | | | |
5/9/19 18:05 | 5/7/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Makhzoumi Mohamad | CA | T | | P.d | 1,228 | 1.08 | 0 | 1,137 | 124 | 2,052 | I | | | | | | | | | | | | | | |
5/9/19 18:05 | 5/7/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Florence Anthony A. Jr. | MD | T | | P.d | 1,228 | 1.08 | 0 | 1,137 | 124 | 2,052 | I | | | | | | | | | | | | | | |
5/9/19 18:05 | 5/7/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Chang Carmen | CA | T | | P.d | 1,228 | 1.08 | 0 | 1,137 | 124 | 2,052 | I | | | | | | | | | | | | | | |
5/9/19 18:04 | 5/7/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Behbahani Ali | MD | T | | P.d | 1,228 | 1.08 | 0 | 1,137 | 124 | 2,052 | I | | | | | | | | | | | | | | |
5/9/19 18:04 | 5/7/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Baskett Forest | MD | T | | P.d | 1,228 | 1.08 | 0 | 1,137 | 124 | 2,052 | I | | | | | | | | | | | | | | |
5/9/19 18:02 | 5/7/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Barris Peter J | MD | T | | P.d | 1,228 | 1.08 | 0 | 1,137 | 124 | 2,052 | I | | | | | | | | | | | | | | |
5/9/19 18:02 | 5/7/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Growth Equity Opportunities V, LLC | MD | T | | P.d | 1,228 | 1.08 | 0 | 1,137 | 124 | 2,052 | D | | | | | | | | | | | | | | |
5/8/19 17:15 | 5/7/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Hagan Joseph P | CA | DO | P,CEO | P.d | 36 | 1.08 | 0 | 33 | 106 | 65 | D | | | | | | | | | | | | | | |
5/8/19 17:15 | 5/7/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Witz Pascale | CA | D | | P.d | 32 | 1.08 | 0 | 30 | 361 | 38 | D | | | | | | | | | | | | | | |
5/8/19 17:14 | 5/7/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Rastetter William H | CA | D | | P.d | 100 | 1.08 | 0 | 93 | 151 | 154 | I | | | | | | | | | | | | | | |
5/8/19 17:13 | 5/7/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Papadopoulos Stelios | CA | D | | P.d | 400 | 1.08 | 0 | 370 | 45 | 1,190 | D | | | | | | | | | | | | | | |
4/3/19 16:31 | 4/1/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Hagan Joseph P | CA | DO | P,CEO | S | -6 | 0.9810 | 0 | -6 | -16 | 31 | D | | | | | | | | | | | | | | |
4/3/19 16:16 | 4/1/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO | S | -3 | 0.9814 | 0 | -3 | -26 | 9 | D | | | | | | | | | | | | | | |
4/3/19 16:15 | 4/1/19 | RGLS | Health | Drug | Pharmaceutical Preparations | Aker Christopher Ray | CA | O | SVP,GC | S | -3 | 0.9812 | 0 | -3 | -30 | 6 | D | | | | | | | | | | | | | | |
1/2/19 16:12 | 12/28/18 | RGLS | Health | Drug | Pharmaceutical Preparations | Papadopoulos Stelios | CA | D | | P | 55 | 1.09 | 0 | 50 | 6 | 835 | D | | | | | | | | | | | | | | |
12/28/18 16:21 | 12/26/18 | RGLS | Health | Drug | Pharmaceutical Preparations | Papadopoulos Stelios | CA | D | | P.m | 113 | 0.9737 | 0 | 116 | 17 | 785 | D | | | | | | | | | | | | | | |
11/19/18 16:03 | 11/15/18 | RGLS | Health | Drug | Pharmaceutical Preparations | Papadopoulos Stelios | CA | D | | P.m | 681 | 1.36 | 0 | 500 | 296 | 669 | D | | | | | | | | | | | | | | |
11/19/18 16:01 | 11/16/18 | RGLS | Health | Drug | Pharmaceutical Preparations | Collier Kathryn J | CA | D | | P | 10 | 1.41 | 0 | 7 | 35 | 28 | D | | | | | | | | | | | | | | |
7/25/17 18:09 | 7/25/17 | RGLS | Health | Drug | Pharmaceutical Preparations | Wright Timothy Michael | CA | O | Chief R, | P | 250 | 0.9100 | 0 | 275 | New | 275 | D | | | | | | | | | | | | | | |
7/25/17 18:09 | 7/25/17 | RGLS | Health | Drug | Pharmaceutical Preparations | Rastetter William H | CA | D | | P | 250 | 0.9100 | 0 | 275 | 79 | 625 | I | | | | | | | | | | | | | | |
7/25/17 18:08 | 7/25/17 | RGLS | Health | Drug | Pharmaceutical Preparations | Hagan Joseph P | CA | DO | P,CEO | P | 200 | 0.9100 | 0 | 220 | 999% | 241 | D | | | | | | | | | | | | | | |
7/25/17 18:07 | 7/25/17 | RGLS | Health | Drug | Pharmaceutical Preparations | Chevallard Daniel R. | CA | O | CFO | P | 50 | 0.9100 | 0 | 55 | 999% | 59 | D | | | | | | | | | | | | | | |
7/25/17 18:06 | 7/25/17 | RGLS | Health | Drug | Pharmaceutical Preparations | Papadopoulos Stelios | CA | D | | P | 910 | 0.9100 | 0 | 1,000 | 130 | 1,771 | D | | | | | | | | | | | | | | |
3/23/17 16:26 | 3/21/17 | RGLS | Health | Drug | Pharmaceutical Preparations | Papadopoulos Stelios | CA | D | | P.m | 608 | 1.22 | 1 | 500 | 249 | 701 | D | -93 | -82 | -64 | -49 | -4 | 14 | -7 | -2 | 12 | 32 | 12 | | | |
3/7/17 16:59 | 3/7/17 | RGLS | Health | Drug | Pharmaceutical Preparations | Rastetter William H | CA | D | | P | 288 | 1.15 | 1 | 250 | 250 | 350 | I | -95 | -84 | -64 | -53 | -50 | -8 | 8 | 8 | 13 | 18 | 40 | | | |
3/7/16 17:20 | 3/3/16 | RGLS | Health | Drug | Pharmaceutical Preparations | Hagan Joseph P | CA | O | COO | P | 72 | 7.19 | 10 | 10 | New | 10 | D | -37 | -66 | -22 | -26 | 12 | 24 | 6 | 4 | -6 | -13 | 5 | -27 | -64 | -92 |
2/24/16 18:20 | 2/23/16 | RGLS | Health | Drug | Pharmaceutical Preparations | Alnylam Pharmaceuticals, Inc. | MA | T | | S | -7,180 | 7.18 | 9 | -1,000 | -17 | 4,897 | D | -34 | -62 | -11 | -25 | 4 | 25 | 20 | -12 | -6 | 2 | -5 | -16 | -48 | -82 |
8/13/15 18:10 | 8/13/15 | RGLS | Health | Drug | Pharmaceutical Preparations | Foletta Mark G | CA | D | | P | 76 | 7.64 | 7 | 10 | New | 10 | D | -4 | 11 | -52 | -42 | -26 | -17 | -3 | 11 | -1 | 1 | 20 | 28 | -19 | -49 |
8/7/15 18:05 | 8/7/15 | RGLS | Health | Drug | Pharmaceutical Preparations | Papadopoulos Stelios | CA | D | | M.d | 79 | 1.55 | 7 | 51 | 34 | 201 | D | -31 | -1 | -60 | -47 | -32 | -32 | -22 | -13 | 1 | 5 | 24 | 29 | -15 | -46 |
7/21/15 20:47 | 7/20/15 | RGLS | Health | Drug | Pharmaceutical Preparations | Rastetter William H | CA | D | | P.m | 1,017 | 10.17 | 8 | 100 | New | 100 | I | 6 | 54 | -42 | -39 | -1 | 3 | 6 | -3 | -7 | -15 | -26 | -29 | -40 | -67 |
7/17/15 18:08 | 7/15/15 | RGLS | Health | Drug | Pharmaceutical Preparations | Isis Pharmaceuticals Inc | CA | T | | S.m | -3,636 | 10.60 | 8 | -343 | -6 | 5,173 | D | 0 | 63 | -40 | -37 | 2 | 5 | 2 | -3 | 1 | -9 | -28 | -37 | -36 | -64 |
7/2/15 16:28 | 6/30/15 | RGLS | Health | Drug | Pharmaceutical Preparations | Isis Pharmaceuticals Inc | CA | T | | S | -143 | 10.79 | 9 | -13 | 0 | 5,516 | D | 6 | 30 | -34 | -40 | -19 | 6 | -1 | 3 | 1 | -3 | -19 | -35 | -9 | -69 |
4/21/15 19:06 | 4/17/15 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | M.dm | 76 | 0.3800 | 9 | 200 | | 84 | D | 149 | 147 | 148 | -5 | -13 | 0 | -1 | -1 | -1 | -18 | -26 | -42 | -61 | -64 |
4/21/15 19:06 | 4/17/15 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | S.dm | -3,429 | 17.15 | 9 | -200 | -70 | 84 | D | 149 | 147 | 148 | -5 | -13 | 0 | -1 | -1 | -1 | -18 | -26 | -42 | -61 | -64 |
4/14/15 17:12 | 4/13/15 | RGLS | Health | Drug | Pharmaceutical Preparations | Carter Bruce L A | CA | D | | M.d | 96 | 4.78 | 10 | 20 | | 0 | D | 159 | 125 | 169 | -9 | -5 | -1 | 1 | -2 | 1 | 0 | -22 | -35 | -59 | -53 |
4/14/15 17:12 | 4/13/15 | RGLS | Health | Drug | Pharmaceutical Preparations | Carter Bruce L A | CA | D | | S.d | -353 | 17.66 | 10 | -20 | -100 | 0 | D | 159 | 125 | 169 | -9 | -5 | -1 | 1 | -2 | 1 | 0 | -22 | -35 | -59 | -53 |
3/5/15 19:17 | 3/5/15 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | M.d | 34 | 0.3800 | 12 | 89 | | 83 | D | 260 | 64 | 163 | 5 | 3 | 14 | 0 | 0 | -2 | -8 | -22 | -54 | -69 | -75 |
3/5/15 19:17 | 3/5/15 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | S.d | -1,808 | 20.26 | 12 | -89 | -52 | 83 | D | 260 | 64 | 163 | 5 | 3 | 14 | 0 | 0 | -2 | -8 | -22 | -54 | -69 | -75 |
3/3/15 17:27 | 2/27/15 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | M.d | 0 | 0.3800 | 13 | 0 | 0 | 83 | D | 261 | 65 | 173 | 0 | 3 | 19 | 4 | -1 | 1 | 8 | -7 | -24 | -54 | -61 |
3/3/15 17:27 | 2/27/15 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | S.d | -1 | 19.50 | 13 | 0 | 0 | 83 | D | 261 | 65 | 173 | 0 | 3 | 19 | 4 | -1 | 1 | 8 | -7 | -24 | -54 | -61 |
2/3/15 17:39 | 1/30/15 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | M.dm | 2 | 0.3800 | 14 | 6 | 7 | 83 | D | 207 | 103 | 198 | 1 | 14 | -2 | 1 | 5 | -4 | -11 | 4 | -23 | -53 | -66 |
2/3/15 17:39 | 1/30/15 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | S.dm | -112 | 19.61 | 14 | -6 | -6 | 83 | D | 207 | 103 | 198 | 1 | 14 | -2 | 1 | 5 | -4 | -11 | 4 | -23 | -53 | -66 |
1/30/15 17:45 | 1/28/15 | RGLS | Health | Drug | Pharmaceutical Preparations | Gibson Neil W | CA | O | Chief Sc | S | -1,444 | 18.05 | 13 | -80 | -100 | 0 | D | 218 | 121 | 181 | 6 | 24 | -5 | 0 | -4 | -4 | -10 | -3 | -36 | -59 | -72 |
1/30/15 17:22 | 1/28/15 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | M.dm | 55 | 0.3800 | 13 | 145 | | 83 | D | 218 | 121 | 181 | 6 | 24 | -5 | 0 | -4 | -4 | -10 | -3 | -36 | -59 | -72 |
1/30/15 17:22 | 1/28/15 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | S.dm | -2,619 | 18.06 | 13 | -145 | -64 | 83 | D | 218 | 121 | 181 | 6 | 24 | -5 | 0 | -4 | -4 | -10 | -3 | -36 | -59 | -72 |
12/15/14 12:58 | 12/12/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Papadopoulos Stelios | CA | D | | M.d | 57 | 0.3800 | 14 | 150 | New | 150 | D | 249 | 162 | 112 | 113 | -20 | -1 | -7 | -6 | -4 | 4 | 12 | 19 | -33 | -51 |
12/1/14 16:49 | 11/28/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Gibson Neil W | CA | O | Chief Sc | M.d | 4 | 1.74 | 29 | 3 | 3 | 80 | D | 332 | 192 | 192 | 172 | 183 | -15 | 3 | 5 | 0 | -2 | -9 | 3 | -33 | -41 |
12/1/14 16:49 | 11/28/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Gibson Neil W | CA | O | Chief Sc | S.d | -48 | 19.30 | 29 | -3 | -3 | 80 | D | 332 | 192 | 192 | 172 | 183 | -15 | 3 | 5 | 0 | -2 | -9 | 3 | -33 | -41 |
11/14/14 16:05 | 11/12/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Astrazeneca Plc | X0 | T | | S | -34,000 | 17.00 | 33 | -2,000 | -32 | 4,250 | I | 277 | 201 | 177 | 153 | 157 | 2 | -12 | -15 | -2 | -8 | -10 | 0 | -26 | -43 |
11/5/14 18:48 | 11/3/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Isis Pharmaceuticals Inc | CA | T | | S | -20,391 | 15.94 | 33 | -1,279 | -19 | 5,516 | D | 325 | 189 | 228 | 188 | 171 | 207 | 17 | 11 | 3 | 7 | -8 | -9 | -30 | -50 |
10/31/14 16:52 | 10/29/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | M.d | 1 | 0.3800 | 33 | 4 | 4 | 83 | D | 258 | 162 | 171 | 195 | 161 | 189 | 170 | -1 | 1 | -2 | -12 | -8 | -35 | -73 |
10/31/14 16:52 | 10/29/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | S.d | -68 | 19.35 | 33 | -4 | -4 | 83 | D | 258 | 162 | 171 | 195 | 161 | 189 | 170 | -1 | 1 | -2 | -12 | -8 | -35 | -73 |
10/31/14 16:50 | 10/29/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Gibson Neil W | CA | O | Chief Sc | M.d | 4 | 1.74 | 33 | 3 | 3 | 80 | D | 258 | 162 | 171 | 195 | 161 | 189 | 170 | -1 | 1 | -2 | -12 | -8 | -35 | -73 |
10/31/14 16:50 | 10/29/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Gibson Neil W | CA | O | Chief Sc | S.d | -48 | 19.29 | 33 | -3 | -3 | 80 | D | 258 | 162 | 171 | 195 | 161 | 189 | 170 | -1 | 1 | -2 | -12 | -8 | -35 | -73 |
10/28/14 17:03 | 10/22/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Isis Pharmaceuticals Inc | CA | DT | | S.am | -1,585 | 14.02 | 33 | -113 | -2 | 6,796 | D | 282 | 155 | 167 | 182 | 149 | 182 | 167 | 34 | 3 | 13 | -1 | 0 | -24 | -60 |
10/28/14 16:59 | 10/22/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Alnylam Pharmaceuticals, Inc. | MA | T | | S.am | -1,585 | 14.02 | 33 | -113 | -2 | 5,897 | D | 282 | 155 | 167 | 182 | 149 | 182 | 167 | 34 | 3 | 13 | -1 | 0 | -24 | -60 |
10/24/14 21:29 | 10/22/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Isis Pharmaceuticals Inc | CA | DT | | S.m | -1,585 | 14.02 | 25 | -113 | -2 | 6,796 | D | 208 | 95 | 116 | 123 | 84 | 111 | 116 | 113 | 6 | 6 | -8 | 14 | -19 | -74 |
10/24/14 21:27 | 10/22/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Alnylam Pharmaceuticals, Inc. | MA | T | | S.m | -1,585 | 14.02 | 25 | -113 | -2 | 5,897 | D | 208 | 95 | 116 | 123 | 84 | 111 | 116 | 113 | 6 | 6 | -8 | 14 | -19 | -74 |
10/24/14 16:16 | 10/22/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Gibson Neil W | CA | O | Chief Sc | M.d | 6 | 1.74 | 25 | 3 | 4 | 80 | D | 208 | 95 | 116 | 123 | 84 | 111 | 116 | 113 | 6 | 6 | -8 | 14 | -19 | -74 |
10/24/14 16:16 | 10/22/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Gibson Neil W | CA | O | Chief Sc | S.d | -48 | 14.44 | 25 | -3 | -4 | 80 | D | 208 | 95 | 116 | 123 | 84 | 111 | 116 | 113 | 6 | 6 | -8 | 14 | -19 | -74 |
10/21/14 16:07 | 10/17/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | M.dm | 0 | 0.3800 | 1 | 1 | 1 | 83 | D | 62 | -21 | -7 | -1 | -9 | 0 | 4 | 3 | 103 | 172 | 166 | 165 | 156 | 2 |
10/21/14 16:07 | 10/17/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | S.dm | -5 | 7.02 | 1 | -1 | -1 | 83 | D | 62 | -21 | -7 | -1 | -9 | 0 | 4 | 3 | 103 | 172 | 166 | 165 | 156 | 2 |
10/17/14 17:38 | 10/15/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Isis Pharmaceuticals Inc | CA | DT | | S.m | -82 | 6.74 | 1 | -12 | 0 | 6,909 | D | 63 | -19 | -1 | 2 | -3 | -3 | 6 | 5 | 3 | 114 | 153 | 165 | 152 | 7 |
10/17/14 17:37 | 10/15/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Alnylam Pharmaceuticals, Inc. | MA | T | | S.m | -82 | 6.74 | 1 | -12 | 0 | 6,010 | D | 63 | -19 | -1 | 2 | -3 | -3 | 6 | 5 | 3 | 114 | 153 | 165 | 152 | 7 |
10/14/14 17:54 | 10/9/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | M.dm | 0 | 0.3800 | 1 | 1 | 1 | 83 | D | 51 | -22 | -7 | 0 | -6 | -6 | -3 | -5 | -2 | 1 | 208 | 169 | 160 | -7 |
10/14/14 17:54 | 10/9/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | S.dm | -4 | 7.00 | 1 | -1 | -1 | 83 | D | 51 | -22 | -7 | 0 | -6 | -6 | -3 | -5 | -2 | 1 | 208 | 169 | 160 | -7 |
10/10/14 18:26 | 10/8/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Isis Pharmaceuticals Inc | CA | DT | | S.m | -66 | 6.56 | 1 | -10 | 0 | 6,921 | D | | -28 | -16 | 1 | -4 | -7 | -4 | -3 | 4 | 9 | 241 | 199 | 172 | 8 |
10/10/14 18:25 | 10/8/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Alnylam Pharmaceuticals, Inc. | MA | T | | S.m | -66 | 6.56 | 1 | -10 | 0 | 6,022 | D | | -28 | -16 | 1 | -4 | -7 | -4 | -3 | 4 | 9 | 241 | 199 | 172 | 8 |
10/3/14 17:20 | 10/1/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Isis Pharmaceuticals Inc | CA | DT | | S.m | -69 | 6.74 | 1 | -10 | 0 | 6,931 | D | | -29 | -13 | -16 | -1 | -14 | -3 | -4 | -2 | -5 | 192 | 151 | 139 | -6 |
10/3/14 17:19 | 10/1/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Alnylam Pharmaceuticals, Inc. | MA | T | | S.m | -69 | 6.74 | 1 | -10 | 0 | 6,032 | D | | -29 | -13 | -16 | -1 | -14 | -3 | -4 | -2 | -5 | 192 | 151 | 139 | -6 |
10/2/14 19:17 | 9/30/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | M.d | 1 | 0.3800 | 1 | 2 | 3 | 83 | D | | -28 | -23 | -17 | -5 | -17 | -4 | -7 | 1 | 2 | 172 | 138 | 153 | -10 |
10/2/14 19:17 | 9/30/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | S.d | -16 | 7.02 | 1 | -2 | -3 | 83 | D | | -28 | -23 | -17 | -5 | -17 | -4 | -7 | 1 | 2 | 172 | 138 | 153 | -10 |
9/26/14 17:37 | 9/24/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Alnylam Pharmaceuticals, Inc. | MA | T | | S.m | -62 | 7.13 | 1 | -9 | 0 | 6,042 | D | | -25 | -20 | -12 | -1 | -1 | -5 | 1 | 0 | -4 | 145 | 109 | 138 | 4 |
9/26/14 17:36 | 9/24/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Isis Pharmaceuticals Inc | CA | DT | | S.m | -62 | 7.13 | 1 | -9 | 0 | 6,941 | D | | -25 | -20 | -12 | -1 | -1 | -5 | 1 | 0 | -4 | 145 | 109 | 138 | 4 |
9/19/14 17:10 | 9/17/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Isis Pharmaceuticals Inc | CA | DT | | S.m | -56 | 7.31 | 0 | -8 | 0 | 6,950 | D | | -18 | -29 | -11 | 10 | 8 | -2 | -2 | -2 | 0 | -5 | 115 | 153 | 29 |
9/19/14 17:09 | 9/17/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Alnylam Pharmaceuticals, Inc. | MA | T | | S.m | -56 | 7.31 | 0 | -8 | 0 | 6,051 | D | | -18 | -29 | -11 | 10 | 8 | -2 | -2 | -2 | 0 | -5 | 115 | 153 | 29 |
9/15/14 17:14 | 9/11/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Gibson Neil W | CA | O | Chief Sc | M.dm | 7 | 1.74 | 0 | 4 | 6 | 80 | D | | -16 | -23 | 10 | 27 | 17 | 13 | 5 | -2 | -7 | -12 | 111 | 147 | 19 |
9/15/14 17:14 | 9/11/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Gibson Neil W | CA | O | Chief Sc | S.dm | -34 | 8.01 | 0 | -4 | -5 | 80 | D | | -16 | -23 | 10 | 27 | 17 | 13 | 5 | -2 | -7 | -12 | 111 | 147 | 19 |
9/12/14 18:26 | 9/10/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Isis Pharmaceuticals Inc | CA | DT | | S.m | -70 | 7.85 | 0 | -9 | 0 | 6,958 | D | | -16 | -25 | 10 | 26 | 16 | 14 | 8 | -4 | -7 | -19 | 103 | 139 | 13 |
9/12/14 18:24 | 9/10/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Alnylam Pharmaceuticals, Inc. | MA | T | | S.m | -70 | 7.85 | 0 | -9 | 0 | 6,059 | D | | -16 | -25 | 10 | 26 | 16 | 14 | 8 | -4 | -7 | -19 | 103 | 139 | 13 |
9/5/14 18:52 | 9/3/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Alnylam Pharmaceuticals, Inc. | MA | T | | S.m | -71 | 7.07 | 0 | -10 | 0 | 6,068 | D | | -24 | -32 | 6 | 6 | 1 | 3 | 4 | 4 | 13 | -3 | 142 | 190 | 19 |
9/5/14 17:57 | 9/3/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Isis Pharmaceuticals Inc | CA | DT | | S.m | -71 | 7.07 | 0 | -10 | 0 | 6,967 | D | | -24 | -32 | 6 | 6 | 1 | 3 | 4 | 4 | 13 | -3 | 142 | 190 | 19 |
8/29/14 19:13 | 8/27/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Isis Pharmaceuticals Inc | CA | DT | | S.m | -35 | 7.00 | 0 | -5 | 0 | 6,977 | D | | -28 | -39 | 1 | 0 | 0 | -8 | -2 | 2 | 4 | 4 | 172 | 172 | 20 |
8/29/14 19:12 | 8/27/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Alnylam Pharmaceuticals, Inc. | MA | T | | S.m | -35 | 7.00 | 0 | -5 | 0 | 6,078 | D | | -28 | -39 | 1 | 0 | 0 | -8 | -2 | 2 | 4 | 4 | 172 | 172 | 20 |
8/29/14 17:19 | 8/28/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | M.d | 1 | 0.3800 | 0 | 4 | 5 | 80 | D | | -28 | -39 | 1 | 0 | 0 | -8 | -2 | 2 | 4 | 4 | 172 | 172 | 20 |
8/29/14 17:19 | 8/28/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | S.d | -25 | 7.06 | 0 | -4 | -4 | 80 | D | | -28 | -39 | 1 | 0 | 0 | -8 | -2 | 2 | 4 | 4 | 172 | 172 | 20 |
8/22/14 19:23 | 8/20/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Alnylam Pharmaceuticals, Inc. | MA | T | | S.m | -74 | 6.89 | 0 | -11 | 0 | 6,083 | D | | -25 | -35 | 11 | 6 | 11 | -1 | -5 | 2 | 0 | 2 | 137 | 171 | 16 |
8/22/14 19:22 | 8/20/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Isis Pharmaceuticals Inc | CA | DT | | S.m | -74 | 6.89 | 0 | -11 | 0 | 6,982 | D | | -25 | -35 | 11 | 6 | 11 | -1 | -5 | 2 | 0 | 2 | 137 | 171 | 16 |
8/15/14 19:12 | 8/13/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Alnylam Pharmaceuticals, Inc. | MA | T | | S.m | -38 | 7.01 | 0 | -5 | 0 | 6,093 | D | | -21 | -24 | 11 | -13 | 9 | 0 | 0 | 4 | -2 | 7 | 178 | 139 | 4 |
8/15/14 19:11 | 8/13/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Isis Pharmaceuticals Inc | CA | DT | | S.m | -38 | 7.01 | 0 | -5 | 0 | 6,992 | D | | -21 | -24 | 11 | -13 | 9 | 0 | 0 | 4 | -2 | 7 | 178 | 139 | 4 |
8/8/14 20:15 | 8/6/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Isis Pharmaceuticals Inc | CA | DT | | S.m | -52 | 6.87 | 0 | -8 | 0 | 6,998 | D | | -30 | -20 | 16 | -16 | -1 | 3 | 1 | 4 | 4 | 9 | 181 | 150 | 3 |
8/8/14 20:08 | 8/6/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Alnylam Pharmaceuticals, Inc. | MA | T | | S.m | -52 | 6.87 | 0 | -8 | 0 | 6,099 | D | | -30 | -20 | 16 | -16 | -1 | 3 | 1 | 4 | 4 | 9 | 181 | 150 | 3 |
8/7/14 17:51 | 8/5/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | M.d | 1 | 0.3800 | 0 | 4 | 5 | 80 | D | | -30 | -14 | 14 | -12 | 7 | 13 | 14 | 1 | 5 | 6 | 192 | 149 | 3 |
8/7/14 17:51 | 8/5/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | S.d | -25 | 7.06 | 0 | -4 | -4 | 80 | D | | -30 | -14 | 14 | -12 | 7 | 13 | 14 | 1 | 5 | 6 | 192 | 149 | 3 |
8/1/14 18:52 | 7/30/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Alnylam Pharmaceuticals, Inc. | MA | T | | S.m | -34 | 6.35 | 0 | -5 | 0 | 6,106 | D | | -37 | -31 | -12 | -23 | -2 | -7 | 3 | 7 | 8 | 11 | 186 | 203 | 31 |
8/1/14 18:44 | 7/30/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Isis Pharmaceuticals Inc | CA | DT | | S.m | -34 | 6.35 | 0 | -5 | 0 | 7,005 | D | | -37 | -31 | -12 | -23 | -2 | -7 | 3 | 7 | 8 | 11 | 186 | 203 | 31 |
7/25/14 20:41 | 7/23/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Isis Pharmaceuticals Inc | CA | DT | | S.m | -35 | 6.75 | 1 | -5 | 0 | 7,011 | D | | -35 | -19 | -6 | -7 | -17 | 2 | 1 | -4 | -2 | 4 | 107 | 178 | 39 |
7/25/14 20:40 | 7/23/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Alnylam Pharmaceuticals, Inc. | MA | T | | S.m | -35 | 6.75 | 1 | -5 | 0 | 6,112 | D | | -35 | -19 | -6 | -7 | -17 | 2 | 1 | -4 | -2 | 4 | 107 | 178 | 39 |
7/18/14 19:19 | 7/16/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Isis Pharmaceuticals Inc | CA | DT | | S.m | -90 | 6.66 | 1 | -14 | 0 | 7,016 | D | | -32 | -12 | -5 | -2 | -17 | -8 | 0 | -1 | 0 | 4 | -3 | 151 | 53 |
7/18/14 19:17 | 7/16/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Alnylam Pharmaceuticals, Inc. | MA | T | | S.m | -90 | 6.66 | 1 | -14 | 0 | 6,117 | D | | -32 | -12 | -5 | -2 | -17 | -8 | 0 | -1 | 0 | 4 | -3 | 151 | 53 |
7/11/14 20:25 | 7/9/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Isis Pharmaceuticals Inc | CA | DT | | S.m | -54 | 6.73 | 1 | -8 | 0 | 7,030 | D | | -45 | -7 | -20 | -5 | -21 | -18 | -11 | 2 | 2 | 5 | 7 | 200 | 55 |
7/11/14 20:25 | 7/9/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Alnylam Pharmaceuticals, Inc. | MA | T | | S.m | -54 | 6.73 | 1 | -8 | 0 | 6,131 | D | | -45 | -7 | -20 | -5 | -21 | -18 | -11 | 2 | 2 | 5 | 7 | 200 | 55 |
7/7/14 17:19 | 7/2/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Alnylam Pharmaceuticals, Inc. | MA | T | | S.m | -35 | 8.07 | 1 | -4 | 0 | 6,139 | D | | -24 | 10 | 4 | 30 | 13 | 4 | 1 | -3 | -10 | -9 | -6 | 121 | 37 |
7/7/14 17:14 | 7/2/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Isis Pharmaceuticals Inc | CA | T | | S.m | -35 | 8.07 | 1 | -4 | 0 | 7,038 | D | | -24 | 10 | 4 | 30 | 13 | 4 | 1 | -3 | -10 | -9 | -6 | 121 | 37 |
7/2/14 16:39 | 7/1/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Gibson Neil W | CA | O | Chief Sc | M.d | 4 | 1.74 | 1 | 3 | 3 | 80 | D | | -18 | 11 | -5 | 22 | 15 | 0 | 2 | 1 | -10 | -20 | -15 | 99 | 31 |
7/2/14 16:39 | 7/1/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Gibson Neil W | CA | O | Chief Sc | S.d | -20 | 8.10 | 1 | -3 | -3 | 80 | D | | -18 | 11 | -5 | 22 | 15 | 0 | 2 | 1 | -10 | -20 | -15 | 99 | 31 |
7/2/14 16:35 | 7/1/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | M.d | 1 | 0.3800 | 1 | 4 | 5 | 80 | D | | -18 | 11 | -5 | 22 | 15 | 0 | 2 | 1 | -10 | -20 | -15 | 99 | 31 |
7/2/14 16:35 | 7/1/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | S.d | -28 | 8.11 | 1 | -4 | -4 | 80 | D | | -18 | 11 | -5 | 22 | 15 | 0 | 2 | 1 | -10 | -20 | -15 | 99 | 31 |
6/27/14 19:00 | 6/25/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Isis Pharmaceuticals Inc | CA | T | | S.m | -60 | 7.88 | 0 | -8 | 0 | 7,042 | D | | -13 | 3 | -9 | 25 | 16 | -1 | 1 | 2 | 3 | -20 | -11 | 87 | 30 |
6/27/14 18:45 | 6/25/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Alnylam Pharmaceuticals, Inc. | MA | T | | S.m | -60 | 7.88 | 0 | -8 | 0 | 6,143 | D | | -13 | 3 | -9 | 25 | 16 | -1 | 1 | 2 | 3 | -20 | -11 | 87 | 30 |
6/18/14 17:54 | 6/17/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Gibson Neil W | CA | O | Chief Sc | M.d | 9 | 1.74 | 0 | 5 | 7 | 80 | D | | -18 | 28 | -26 | 25 | 17 | 17 | 11 | 2 | -4 | -19 | -9 | 91 | 30 |
6/18/14 17:54 | 6/17/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Gibson Neil W | CA | O | Chief Sc | S.d | -40 | 8.05 | 0 | -5 | -6 | 80 | D | | -18 | 28 | -26 | 25 | 17 | 17 | 11 | 2 | -4 | -19 | -9 | 91 | 30 |
6/9/14 19:31 | 6/9/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | M.d | 1 | 0.3800 | 1 | 4 | 5 | 80 | D | | -25 | 13 | -33 | 2 | 7 | -1 | 10 | -1 | 0 | -1 | -1 | 148 | 48 |
6/9/14 19:31 | 6/9/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | S.d | -25 | 7.14 | 1 | -4 | -4 | 80 | D | | -25 | 13 | -33 | 2 | 7 | -1 | 10 | -1 | 0 | -1 | -1 | 148 | 48 |
5/29/14 19:57 | 5/27/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | M.dm | 1 | 0.3800 | 1 | 4 | 5 | 80 | D | | -7 | 12 | -41 | 2 | 12 | 8 | 11 | -2 | -11 | 16 | 4 | 159 | 97 |
5/29/14 19:57 | 5/27/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | S.dm | -25 | 7.00 | 1 | -4 | -4 | 80 | D | | -7 | 12 | -41 | 2 | 12 | 8 | 11 | -2 | -11 | 16 | 4 | 159 | 97 |
4/10/14 14:51 | 4/9/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Gibson Neil W | CA | O | Chief Sc | M.d | 4 | 1.74 | 1 | 3 | 3 | 80 | D | | 21 | -11 | 17 | -29 | -21 | -9 | 13 | -5 | -15 | -21 | -20 | -15 | 116 |
4/10/14 14:51 | 4/9/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Gibson Neil W | CA | O | Chief Sc | S.d | -20 | 8.11 | 1 | -3 | -3 | 80 | D | | 21 | -11 | 17 | -29 | -21 | -9 | 13 | -5 | -15 | -21 | -20 | -15 | 116 |
4/9/14 14:02 | 3/6/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | M.d | 1 | 0.3800 | 1 | 4 | 5 | 80 | I | | 13 | -22 | 10 | -34 | -27 | -6 | -2 | 7 | -12 | -24 | -7 | -15 | 125 |
4/9/14 14:02 | 3/6/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | S.d | -27 | 7.60 | 1 | -4 | -4 | 80 | I | | 13 | -22 | 10 | -34 | -27 | -6 | -2 | 7 | -12 | -24 | -7 | -15 | 125 |
3/7/14 14:33 | 3/6/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | M.d | 1 | 0.3800 | 3 | 4 | 5 | 80 | I | | 92 | 13 | 72 | 27 | 13 | -9 | -9 | -3 | 2 | -31 | -36 | -32 | 96 |
3/7/14 14:33 | 3/6/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | S.d | -40 | 11.35 | 3 | -4 | -4 | 80 | I | | 92 | 13 | 72 | 27 | 13 | -9 | -9 | -3 | 2 | -31 | -36 | -32 | 96 |
3/7/14 14:29 | 3/6/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Gibson Neil W | CA | O | Chief Sc | M.d | 4 | 1.74 | 3 | 3 | 3 | 80 | D | | 92 | 13 | 72 | 27 | 13 | -9 | -9 | -3 | 2 | -31 | -36 | -32 | 96 |
3/7/14 14:29 | 3/6/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Gibson Neil W | CA | O | Chief Sc | S.d | -28 | 11.37 | 3 | -3 | -3 | 80 | D | | 92 | 13 | 72 | 27 | 13 | -9 | -9 | -3 | 2 | -31 | -36 | -32 | 96 |
2/7/14 15:09 | 2/5/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | M.d | 1 | 0.3800 | 2 | 4 | 5 | 80 | I | | 40 | -12 | 21 | 8 | 6 | -5 | -1 | 3 | 11 | 24 | -31 | -20 | 100 |
2/7/14 15:09 | 2/5/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | S.d | -29 | 8.40 | 2 | -4 | -4 | 80 | I | | 40 | -12 | 21 | 8 | 6 | -5 | -1 | 3 | 11 | 24 | -31 | -20 | 100 |
2/7/14 15:04 | 2/5/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Gibson Neil W | CA | O | Chief Sc | M.dm | 83 | 1.74 | 2 | 48 | 146 | 80 | D | | 40 | -12 | 21 | 8 | 6 | -5 | -1 | 3 | 11 | 24 | -31 | -20 | 100 |
2/7/14 15:04 | 2/5/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Gibson Neil W | CA | O | Chief Sc | S.d | -147 | 8.38 | 2 | -18 | -18 | 80 | D | | 40 | -12 | 21 | 8 | 6 | -5 | -1 | 3 | 11 | 24 | -31 | -20 | 100 |
2/5/14 15:38 | 2/4/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Sanofi | I0 | T | | P | 10,000 | 7.67 | 2 | 1,304 | 35 | 5,054 | I | | 49 | -18 | 28 | 27 | 19 | 8 | -7 | -5 | 7 | 22 | -25 | -18 | 98 |
1/23/14 14:33 | 1/21/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Gibson Neil W | CA | O | Chief Sc | M.d | 12 | 2.66 | 2 | 4 | 10 | 50 | D | | 45 | -20 | 0 | 29 | 9 | 17 | 2 | 3 | 4 | 33 | -12 | -15 | 127 |
1/23/14 14:33 | 1/21/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Gibson Neil W | CA | O | Chief Sc | S.d | -36 | 8.09 | 2 | -4 | -8 | 50 | D | | 45 | -20 | 0 | 29 | 9 | 17 | 2 | 3 | 4 | 33 | -12 | -15 | 127 |
1/21/14 16:03 | 1/17/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Gibson Neil W | CA | O | Chief Sc | M.d | 10 | 2.17 | 2 | 4 | 10 | 50 | D | | 49 | -22 | -8 | 29 | 6 | 12 | 9 | -6 | -9 | 22 | -20 | -24 | 126 |
1/21/14 16:03 | 1/17/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Gibson Neil W | CA | O | Chief Sc | S.d | -36 | 8.15 | 2 | -4 | -8 | 50 | D | | 49 | -22 | -8 | 29 | 6 | 12 | 9 | -6 | -9 | 22 | -20 | -24 | 126 |
1/17/14 13:35 | 1/16/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Gibson Neil W | CA | O | Chief Sc | M.d | 2 | 1.74 | 2 | 1 | 2 | 50 | D | | 56 | -19 | -7 | 30 | 5 | 13 | 9 | 0 | 1 | 25 | -12 | -14 | 128 |
1/17/14 13:35 | 1/16/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Gibson Neil W | CA | O | Chief Sc | S.d | -9 | 8.03 | 2 | -1 | -2 | 50 | D | | 56 | -19 | -7 | 30 | 5 | 13 | 9 | 0 | 1 | 25 | -12 | -14 | 128 |
1/2/14 20:52 | 1/2/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | M.d | 1 | 0.3800 | 1 | 4 | 5 | 80 | I | | 17 | -30 | -20 | 19 | 23 | 13 | -1 | -3 | -4 | 24 | 17 | 9 | 117 |
1/2/14 20:52 | 1/2/14 | RGLS | Health | Drug | Pharmaceutical Preparations | Xanthopoulos Kleanthis G | CA | DO | P,CEO | S.d | -25 | 7.25 | 1 | -4 | -4 | 80 | I | | 17 | -30 | -20 | 19 | 23 | 13 | -1 | -3 | -4 | 24 | 17 | 9 | 117 |
2/14/13 21:08 | 2/4/13 | RGLS | Health | Drug | Pharmaceutical Preparations | Gibson Neil W | CA | O | Chief Sc | M.d | 87 | 1.74 | 0 | 50 | New | 50 | D | | | | 15 | -12 | -4 | -3 | 0 | -5 | -9 | 19 | 28 | 57 | 64 |
10/11/12 19:56 | 10/10/12 | RGLS | Health | Drug | Pharmaceutical Preparations | Isis Pharmaceuticals Inc | CA | T | | P.d | 3,000 | 4.00 | 0 | 750 | 12 | 7,050 | D | | | | | | | | | 2 | 1 | 18 | 14 | 71 | 108 |
10/11/12 19:53 | 10/10/12 | RGLS | Health | Drug | Pharmaceutical Preparations | Parshall B Lynne | CA | DT | | P.d | 3,000 | 4.00 | 0 | 750 | 12 | 7,050 | I | | | | | | | | | 2 | 1 | 18 | 14 | 71 | 108 |
10/11/12 19:52 | 10/10/12 | RGLS | Health | Drug | Pharmaceutical Preparations | Crooke Stanley T | CA | DT | | P.d | 3,000 | 4.00 | 0 | 750 | 12 | 7,050 | I | | | | | | | | | 2 | 1 | 18 | 14 | 71 | 108 |